Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper

Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in adults, particularly older adults and those with underlying medical conditions. Vaccination has emerged as a potential key strategy to prevent RSV-related morbidity and mortality. This Neumoexperts Prevention (NEP)...

Descripción completa

Detalles Bibliográficos
Autores: Redondo, Esther, Rivero-Calle, Irene, Mascarós, Enrique, Ocaña, Daniel, Jimeno, Isabel, Gil, Ángel, Linares, Manuel, Onieva-García, María Ángeles, González-Romo, Fernando, Yuste, Jose Enrique, Martinón-Torres, Federico
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/19045
Acceso en línea:http://hdl.handle.net/20.500.12105/19045
Access Level:acceso abierto
Palabra clave:Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus Infections
Respiratory Tract Infections
Humans
Middle Aged
Aged
Vaccination
id ES_f97508d8a80059d93e88ea3ebad9f34c
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/19045
network_acronym_str ES
network_name_str España
repository_id_str
spelling Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position PaperRedondo, EstherRivero-Calle, IreneMascarós, EnriqueOcaña, DanielJimeno, IsabelGil, ÁngelLinares, ManuelOnieva-García, María ÁngelesGonzález-Romo, FernandoYuste, Jose EnriqueMartinón-Torres, FedericoRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsHumansMiddle AgedAgedVaccinationRespiratory syncytial virus (RSV) is a major cause of respiratory tract infections in adults, particularly older adults and those with underlying medical conditions. Vaccination has emerged as a potential key strategy to prevent RSV-related morbidity and mortality. This Neumoexperts Prevention (NEP) Group scientific paper aims to provide an evidence-based positioning and RSV vaccination recommendations for adult patients. We review the current literature on RSV burden and vaccine development and availability, emphasising the importance of vaccination in the adult population. According to our interpretation of the data, RSV vaccines should be part of the adult immunisation programme, and an age-based strategy should be preferred over targeting high-risk groups. The effectiveness and efficiency of this practice will depend on the duration of protection and the need for annual or more spaced doses. Our recommendations should help healthcare professionals formulate guidelines and implement effective vaccination programmes for adult patients at risk of RSV infection now that specific vaccines are available.ElsevierCentro de Investigación Biomédica en Red - CIBERES (Enfermedades Respiratorias)Instituto de Salud Carlos IIIUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)Xunta de Galicia (España)20242024-03-2220242024-03-0120242024-03-01review articlehttp://purl.org/coar/resource_type/c_dcae04bcVoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfapplication/pdfhttp://hdl.handle.net/20.500.12105/19045reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Atribución 4.0 Internacionalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/190452026-06-12T12:43:37Z
dc.title.none.fl_str_mv Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
title Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
spellingShingle Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
Redondo, Esther
Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus Infections
Respiratory Tract Infections
Humans
Middle Aged
Aged
Vaccination
title_short Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
title_full Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
title_fullStr Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
title_full_unstemmed Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
title_sort Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
dc.creator.none.fl_str_mv Redondo, Esther
Rivero-Calle, Irene
Mascarós, Enrique
Ocaña, Daniel
Jimeno, Isabel
Gil, Ángel
Linares, Manuel
Onieva-García, María Ángeles
González-Romo, Fernando
Yuste, Jose Enrique
Martinón-Torres, Federico
author Redondo, Esther
author_facet Redondo, Esther
Rivero-Calle, Irene
Mascarós, Enrique
Ocaña, Daniel
Jimeno, Isabel
Gil, Ángel
Linares, Manuel
Onieva-García, María Ángeles
González-Romo, Fernando
Yuste, Jose Enrique
Martinón-Torres, Federico
author_role author
author2 Rivero-Calle, Irene
Mascarós, Enrique
Ocaña, Daniel
Jimeno, Isabel
Gil, Ángel
Linares, Manuel
Onieva-García, María Ángeles
González-Romo, Fernando
Yuste, Jose Enrique
Martinón-Torres, Federico
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Centro de Investigación Biomédica en Red - CIBERES (Enfermedades Respiratorias)
Instituto de Salud Carlos III
Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
Xunta de Galicia (España)
dc.subject.none.fl_str_mv Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus Infections
Respiratory Tract Infections
Humans
Middle Aged
Aged
Vaccination
topic Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus Infections
Respiratory Tract Infections
Humans
Middle Aged
Aged
Vaccination
description Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in adults, particularly older adults and those with underlying medical conditions. Vaccination has emerged as a potential key strategy to prevent RSV-related morbidity and mortality. This Neumoexperts Prevention (NEP) Group scientific paper aims to provide an evidence-based positioning and RSV vaccination recommendations for adult patients. We review the current literature on RSV burden and vaccine development and availability, emphasising the importance of vaccination in the adult population. According to our interpretation of the data, RSV vaccines should be part of the adult immunisation programme, and an age-based strategy should be preferred over targeting high-risk groups. The effectiveness and efficiency of this practice will depend on the duration of protection and the need for annual or more spaced doses. Our recommendations should help healthcare professionals formulate guidelines and implement effective vaccination programmes for adult patients at risk of RSV infection now that specific vaccines are available.
publishDate 2024
dc.date.none.fl_str_mv 2024
2024-03-22
2024
2024-03-01
2024
2024-03-01
dc.type.none.fl_str_mv review article
http://purl.org/coar/resource_type/c_dcae04bc
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12105/19045
url http://hdl.handle.net/20.500.12105/19045
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Atribución 4.0 Internacional
http://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Atribución 4.0 Internacional
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repisalud
instname:Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
reponame_str Repisalud
collection Repisalud
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869425096533213184
score 15,812429

Similares en LA Referencia